TVAX Biomedical, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct's, 'TVAX Biomedical, Inc. - Product Pipeline Review - 2016', provides an overview of the TVAX Biomedical, Inc.'s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by TVAX Biomedical, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of TVAX Biomedical, Inc. - The report provides overview of TVAX Biomedical, Inc. including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses TVAX Biomedical, Inc.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features TVAX Biomedical, Inc.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons to Buy - Evaluate TVAX Biomedical, Inc.'s strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for TVAX Biomedical, Inc. - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding TVAX Biomedical, Inc.'s pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 TVAX Biomedical, Inc. Snapshot 5 TVAX Biomedical, Inc. Overview 5 Key Information 5 Key Facts 5 TVAX Biomedical, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 TVAX Biomedical, Inc. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 TVAX Biomedical, Inc. - Pipeline Products Glance 10 TVAX Biomedical, Inc. - Clinical Stage Pipeline Products 10 Phase II Products/Combination Treatment Modalities 10 Phase I Products/Combination Treatment Modalities 11 TVAX Biomedical, Inc. - Early Stage Pipeline Products 12 Preclinical Products/Combination Treatment Modalities 12 TVAX Biomedical, Inc. - Drug Profiles 13 TVI-Brain-1 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 TVI-Kidney-1 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 TVI-Breast-1 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 TVI-Colon-1 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 TVI-Leukemia-1 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 TVI-Lung-1 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 TVI-Melanoma-1 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 TVI-Ovary-1 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 TVI-Pancreas-1 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 TVI-Prostate-1 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 TVI-Hepatitis-1 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 TVI-HIV-1 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 TVI-Tuberculosis-1 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 TVAX Biomedical, Inc. - Pipeline Analysis 27 TVAX Biomedical, Inc. - Pipeline Products by Route of Administration 27 TVAX Biomedical, Inc. - Pipeline Products by Molecule Type 28 TVAX Biomedical, Inc. - Recent Pipeline Updates 29 TVAX Biomedical, Inc. - Locations And Subsidiaries 30 Head Office 30 Appendix 31 Methodology 31 Coverage 31 Secondary Research 31 Primary Research 31 Expert Panel Validation 31 Contact Us 31 Disclaimer 32
List of Tables
TVAX Biomedical, Inc., Key Information 5 TVAX Biomedical, Inc., Key Facts 5 TVAX Biomedical, Inc. - Pipeline by Indication, 2016 7 TVAX Biomedical, Inc. - Pipeline by Stage of Development, 2016 8 TVAX Biomedical, Inc. - Monotherapy Products in Pipeline, 2016 9 TVAX Biomedical, Inc. - Phase II, 2016 10 TVAX Biomedical, Inc. - Phase I, 2016 11 TVAX Biomedical, Inc. - Preclinical, 2016 12 TVAX Biomedical, Inc. - Pipeline by Route of Administration, 2016 27 TVAX Biomedical, Inc. - Pipeline by Molecule Type, 2016 28 TVAX Biomedical, Inc. - Recent Pipeline Updates, 2016 29
List of Figures
TVAX Biomedical, Inc. - Pipeline by Top 10 Indication, 2016 7 TVAX Biomedical, Inc. - Pipeline by Stage of Development, 2016 8 TVAX Biomedical, Inc. - Monotherapy Products in Pipeline, 2016 9 TVAX Biomedical, Inc. - Pipeline by Route of Administration, 2016 27 TVAX Biomedical, Inc. - Pipeline by Molecule Type, 2016 28
Global air traffic control equipment market is projected to reach USD 4.2 billion by 2020, as per a new research report by Radiant Insights, Inc. Mounting price sensitivity among customers with introduction of low fare airlines is expected to drive tRead More...
Global lignin market size is expected to exceed USD 6 billion by 2022, growing at 4.9% from 2015 to 2022. Rising demand for animal feed and potential as a feedstock substitute to crude oil are expected to drive lignin market demand over the forecastRead More...
Global fingerprint access control systems market size is estimated to reach USD 4.4 billion by 2022, as per a new research report by Radiant Insights, Inc. Growing safety and security concerns of individual as well as organization is projected to driRead More...
Global outsourced customer care services market is projected to reach USD 84.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Swelling need for interaction through non-voice channels is estimated to boost global demand over tRead More...
Global Bio polyethylene terephthalate (PET) market size is likely to be valued at USD 12.6 billion by 2020; as per a new research report by Radiant Insights, Inc. Growing preference of biopolymers in numerous applications coupled with favorable goverRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.